Science Reviews - Biology, 2023, 2(2), 30 - 39                                                                                                   Raquel Rodrigues  
 
 
Using spore-forming bacteria to treat cancer: recent 
advancements in clostridial-based therapies 
 
Raquel Rodrigues, PhD 
  Independent Researcher, Aveiro, Portugal; raquel.sof.rodrigues@gmail.com 
https://orcid.org/0000-0002-2903-3258 
 
 
References 
Abedi Jafari, F., Abdoli, A., Pilehchian, R., Soleimani, N., & Hosseini, S. M. (2022). The oncolytic ac-
tivity  of  Clostridium  novyi  nontoxic  spores  in  breast  cancer.  Bioimpacts,  12(5),  405-414. 
https://doi.org/10.34172/bi.2021.25 
Andryukov, B. G., Karpenko, A. A., & Lyapun, I. N. (2021). Learning from Nature: Bacterial Spores 
as a Target for Current Technologies in Medicine (Review). Sovrem Tekhnologii Med, 12(3), 105-122. 
https://doi.org/10.17691/stm2020.12.3.13 
Bae, G.-H., Ryu, Y.-H., Han, J., Kim, S. H., Park, C. G., Park, J.-H., . . . Park, W. (2023). Multifunctional 
porous microspheres encapsulating oncolytic bacterial spores and their potential for cancer immuno-
therapy. Biomaterials Science, 11(13), 4652-4663. https://doi.org/10.1039/D3BM00635B 
Barbé, S., Van Mellaert, L., Theys, J., Geukens, N., Lammertyn, E., Lambin, P., & Anné, J. (2005). Se-
cretory production of biologically active rat interleukin-2 by Clostridium acetobutylicum DSM792 as 
a  tool  for  anti-tumor  treatment.  FEMS  Microbiology  Letters,  246(1),  67-73. 
https://doi.org/10.1016/j.femsle.2005.03.037. 
Bettegowda, C., Huang, X., Lin, J., Cheong, I., Kohli, M., Szabo, S. A., . . . Zhou, S. (2006). The genome 
and  transcriptomes  of  the  anti-tumor  agent  Clostridium  novyi-NT.  Nature  Biotechnology,  24(12), 
1573-1580. https://doi.org/10.1038/nbt1256.  
Cano, R., & Borucki, M. (1995). Revival and identification of bacterial spores in 25- to 40-million-year-
old  Dominican  amber.  Science,  268(5213),  1060-1064.  Retrieved  from  http://science.science-
mag.org/content/sci/268/5213/1060.full.pdf. https://doi.org/10.1126/science.7538699 
Collins, M. D., Lawson, P. A., Willems, A., Cordoba, J. J., Fernandez-Garayzabal, J., Garcia, P., . . . 
Farrow, J. A. E. (1994). The phylogeny of the genus Clostridium:  proposal of five new genera and 
eleven new species combinations. International Journal of Systematic and Evolutionary Microbiol-
ogy,  44(4),  812-826.  Retrieved  from  http://ijs.microbiologyresearch.org/content/jour-
nal/ijsem/10.1099/00207713-44-4-812.   https://doi.org/10.1099/00207713-44-4-812 
Dang, L. H., Bettegowda, C., Huso, D. L., Kinzler, K. W., & Vogelstein, B. (2001). Combination bacte-
riolytic therapy for the treatment of experimental tumors. Proceedings of the National Academy of 
Sciences,  98(26),  15155-15160.  Retrieved  from  https://www.pnas.org/con-
tent/pnas/98/26/15155.full.pdf. https://doi.org/10.1073/pnas.251543698 
Desvaux, M., Guedon, E., & Petitdemange, H. (2000). Cellulose catabolism by Clostridium celluloly-
ticum growing in batch culture on defined medium. Applied and Environmental Microbiology, 66(6), 
2461-2470. Retrieved from http://aem.asm.org/content/66/6/2461.abstract.   
https://doi.org/10.1128/aem.66.6.2461-2470.2000 
Diaz, L. A., Jr., Cheong, I., Foss, C. A., Zhang, X., Peters, B. A., Agrawal, N., . . . Huso, D. L. (2005). 
Pharmacologic and toxicologic evaluation of C. novyi-NT spores. Toxicological Sciences, 88(2), 562-
575. https://doi.org/10.1093/toxsci/kfi316.  

Raquel Rodrigues Science Reviews - Biology, 2023, 2(2), 30 - 39

Galperin, M. Y., Mekhedov, S. L., Puigbo, P., Smirnov, S., Wolf, Y. I., & Rigden, D. J. (2012). Genomic

determinants of sporulation in Bacilli and Clostridia: towards the minimal set of sporulation-specific

genes. Environmental Microbiology, 14(11), 2870-2890. https://doi.org/10.1111/j.1462-

2920.2012.02841.x

Gu, Y., Patterson, A. V., Atwell, G. J., Chernikova, S. B., Brown, J. M., Thompson, L. H., & Wilson, W.

R. (2009). Roles of DNA repair and reductase activity in the cytotoxicity of the hypoxia-activated

dinitrobenzamide mustard PR-104A. Molecular Cancer Therapeutics, 8(6), 1714-1723.

https://doi.org/10.1158/1535-7163.MCT-08-1209.

Heap, J. T., Theys, J., Ehsaan, M., Kubiak, A. M., Dubois, L., Paesmans, K., . . . Minton, N. P. (2014).

Spores of Clostridium engineered for clinical efficacy and safety cause regression and cure of tumors

in vivo. Oncotarget, 5(7), 1761-1769. Retrieved from http://www.impactjournals.com/oncotar-

get/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=1761.

https://doi.org/10.18632/oncotarget.1761

Helsby, N. A., Ferry, D. M., Patterson, A. V., Pullen, S. M., & Wilson, W. R. (2004). 2-Amino metabo-

lites are key mediators of CB 1954 and SN 23862 bystander effects in nitroreductase GDEPT. British

journal of cancer, 90(5), 1084-1092. https://doi.org/10.1038/sj.bjc.6601612.

Janku, F., Zhang, H. H., Pezeshki, A., Goel, S., Murthy, R., Wang-Gillam, A., . . . Gounder, M. M.

(2021). Intratumoral injection of Clostridium novyi-NT spores in patients with treatment-refractory

advanced solid tumors. Clinical Cancer Research, 27(1), 96-106. https://doi.org/10.1158/1078-

0432.CCR-20-2065.

Karnofsky, D. A. (1968). Mechanisms of action of anticancer drugs at a cellular level. Ca: A Cancer

Journal For Clinicians, 18(4), 232-234. https://doi.org/10.3322/canjclin.18.4.232

Kennedy, M. J., Reader, S. L., & Swierczynski, L. M. (1994). Preservation records of micro-organisms:

evidence of the tenacity of life. Microbiology, 140(10), 2513-2529. Retrieved from http://mic.microbi-

ologyresearch.org/content/journal/micro/10.1099/00221287-140-10-2513.

https://doi.org/10.1099/00221287-140-10-2513

Kubiak, A. M., Bailey, T. S., Dubois, L. J., Theys, J., & Lambin, P. (2021). Efficient secretion of murine

IL-2 from an attenuated strain of Clostridium sporogenes, a novel delivery vehicle for cancer immu-

notherapy. Frontiers in microbiology, 12. Retrieved from https://www.frontiersin.org/arti-

cles/10.3389/fmicb.2021.669488. https://doi.org/10.3389/fmicb.2021.669488

Kubiak, A. M., & Minton, N. P. (2015). The potential of clostridial spores as therapeutic delivery ve-

hicles in tumour therapy. Research in Microbiology, 166(4), 244-254. Retrieved from http://www.sci-

encedirect.com/science/article/pii/S0923250814002551.

https://doi.org/10.1016/j.resmic.2014.12.006

Kubiak, A. M., Poehlein, A., Budd, P., Kuehne, S. A., Winzer, K., Theys, J., . . . Minton, N. P. (2015).

Complete genome sequence of the nonpathogenic soil-dwelling bacterium Clostridium sporogenes

strain NCIMB 10696. Genome Announcements, 3(4), e00942-00915. Retrieved from http://ge-

nomea.asm.org/content/3/4/e00942-15.abstract. https://doi.org/10.1128/genomeA.00942-15

Lamed, R., & Zeikus, J. G. (1980). Ethanol production by thermophilic bacteria: relationship between

fermentation product yields of and catabolic enzyme activities in Clostridium thermocellum and

Thermoanaerobium brockii. Journal of Bacteriology, 144(2), 569-578. Retrieved from

http://www.ncbi.nlm.nih.gov/pmc/articles/PMC294704/.

Ludwig, W., Schleifer, K., & Whitman, W. B. (2015). Bacilli class. nov. In Bergey's Manual of System-

atics of Archaea and Bacteria (pp. 1-1).

Minton, N. P., Mauchline, M. L., Lemmon, M. J., Brehm, J. K., Fox, M., Michael, N. P., . . . Brown, J.

M. (1995). Chemotherapeutic tumour targeting using clostridial spores. FEMS Microbiology Reviews,

17(3), 357-364. https://doi.org/10.1111/j.1574-6976.1995.tb00219.x.

Science Reviews - Biology, 2023, 2(2), 30 - 39 Raquel Rodrigues

Möse, J. R., & Möse, G. (1964). Oncolysis by clostridia. I. Activity of Clostridium butyricum (M-55)

and other nonpathogenic clostridia against the Ehrlich carcinoma. Cancer Research, 24(2 Part 1), 212-

216. Retrieved from http://cancerres.aacrjournals.org/content/24/2_Part_1/212.abstract.

Mowday, A. M., Dubois, L. J., Kubiak, A. M., Chan-Hyams, J. V. E., Guise, C. P., Ashoorzadeh, A., . . .

Patterson, A. V. (2022). Use of an optimised enzyme/prodrug combination for Clostridia directed

enzyme prodrug therapy induces a significant growth delay in necrotic tumours. Cancer Gene Ther-

apy, 29(2), 178-188. https://doi.org/10.1038/s41417-021-00296-7.

Napoli, F., Olivieri, G., Russo, M. E., Marzocchella, A., & Salatino, P. (2010). Butanol production by

Clostridium acetobutylicum in a continuous packed bed reactor. Journal of Industrial Microbiology

& Biotechnology, 37(6), 603-608. https://doi.org/10.1007/s10295-010-0707-8.

Parker, R. C., Plummer, H. C., Siebenmann, C. O., & Chapman, M. G. (1947). Effect of histolyticus

infection and toxin on transplantable mouse tumors. Proceedings of the Society for Experimental Bi-

ology and Medicine, 66(2), 461-467. Retrieved from https://jour-

nals.sagepub.com/doi/abs/10.3181/00379727-66-16124. https://doi.org/10.3181/00379727-66-

16124

Pokrovsky, V. S., Anisimova, N. Y., Davydov, D. Z., Bazhenov, S. V., Bulushova, N. V., Zavilgelsky,

G. B., . . . Manukhov, I. V. (2019). Methionine gamma lyase from Clostridium sporogenes increases

the anticancer efficacy of doxorubicin on A549 cancer cells in vitro and human cancer xenografts. In

R. M. Hoffman (Ed.), Methionine Dependence of Cancer and Aging: Methods and Protocols (pp. 243-

261). New York, NY: Springer New York.

Rautio, J., Kumpulainen, H., Heimbach, T., Oliyai, R., Oh, D., Jarvinen, T., & Savolainen, J. (2008).

Prodrugs: design and clinical applications. Nat Rev Drug Discov, 7(3), 255-270.

https://doi.org/10.1038/nrd2468

Roberts, N. J., Zhang, L., Janku, F., Collins, A., Bai, R. Y., Staedtke, V., . . . Zhou, S. (2014). Intratumoral

injection of Clostridium novyi-NT spores induces antitumor responses. Sci Transl Med, 6(249),

249ra111. https://doi.org/10.1126/scitranslmed.3008982

Setlow, P. (2003). Spore germination. Current Opinion in Microbiology, 6(6), 550-556. Retrieved from

http://www.sciencedirect.com/science/article/pii/S1369527403001371.

https://doi.org/10.1016/j.mib.2003.10.001

Setlow, P. (2007). I will survive: DNA protection in bacterial spores. Trends in Microbiology, 15(4),

172-180. Retrieved from http://www.sciencedirect.com/science/article/pii/S0966842X07000261.

https://doi.org/10.1016/j.tim.2007.02.004

Siegel, R. L., Miller, K. D., Wagle, N. S., & Jemal, A. (2023). Cancer statistics, 2023. Ca: A Cancer Jour-

nal For Clinicians, 73(1), 17-48. Retrieved from https://acsjournals.onlineli-

brary.wiley.com/doi/abs/10.3322/caac.21763. https://doi.org/10.3322/caac.21763

Staedtke, V., Bai, R.-Y., Sun, W., Huang, J., Kibler, K. K., Tyler, B. M., . . . Riggins, G. J. (2015). Clos-

tridium novyi -NT can cause regression of orthotopically implanted glioblastomas in rats. Oncotar-

get, 6(8). Retrieved from https://www.oncotarget.com/article/3627/text/.

Staedtke, V., Gray-Bethke, T., Liu, G., Liapi, E., Riggins, G. J., & Bai, R. Y. (2022). Neutrophil depletion

enhanced the Clostridium novyi-NT therapy in mouse and rabbit tumor models. Neurooncol Adv,

4(1), vdab184. https://doi.org/10.1093/noajnl/vdab184

Tharmalingham, H., & Hoskin, P. (2019). Clinical trials targeting hypoxia. Br J Radiol, 92(1093),

20170966. https://doi.org/10.1259/bjr.20170966

Thiele, E. H., Arison, R. N., & Boxer, G. E. (1964). Oncolysis by clostridia. III. Effects of clostridia and

chemotherapeutic agents on rodent tumors. Cancer Research, 24(2 Part 1), 222-233. Retrieved from

http://cancerres.aacrjournals.org/content/24/2_Part_1/222.abstract.

Raquel Rodrigues Science Reviews - Biology, 2023, 2(2), 30 - 39

Tirandaz, H., Hamedi, J., & Marashi, S.-A. (2006). Application of β-lactamase-dependent prodrugs in

clostridial-directed enzyme therapy (CDEPT): A proposal. Medical Hypotheses, 67(4), 998-999. Re-

trieved from https://www.sciencedirect.com/science/article/pii/S0306987706003409.

https://doi.org/10.1016/j.mehy.2006.05.008

Tran, H. G., Desmet, T., Saerens, K., Waegeman, H., Vandekerckhove, S., D'hooghe, M., . . . Soetaert,

W. (2012). Biocatalytic production of novel glycolipids with cellodextrin phosphorylase. Bioresource

Technology, 115, 84-87. Retrieved from http://www.sciencedirect.com/science/arti-

cle/pii/S0960852411013733. https://doi.org/10.1016/j.biortech.2011.09.085

Weinmann, M., Belka, C., & Plasswilm, L. (2004). Tumour hypoxia: impact on biology, prognosis and

treatment of solid malignant tumours. Oncology Research and Treatment, 27(1), 83-90. Retrieved

from http://www.karger.com/DOI/10.1159/000075611. https://doi.org/10.1159/000075611

Xu, H., Luo, H., Zhang, J., Li, K., & Lee, M. H. (2023). Therapeutic potential of Clostridium butyricum

anticancer effects in colorectal cancer. Gut Microbes, 15(1), 2186114.

https://doi.org/10.1080/19490976.2023.2186114

Zhang, Y. L., Lü, R., Chang, Z. S., Zhang, W. Q., Wang, Q. B., Ding, S. Y., & Zhao, W. (2014). Clostrid-

ium sporogenes delivers interleukin-12 to hypoxic tumours, producing antitumour activity without

significant toxicity. Lett Appl Microbiol, 59(6), 580-586. https://doi.org/10.1111/lam.12322

Zheng, L., Zhang, Z., Khazaie, K., Saha, S., Lewandowski, R. J., Zhang, G., & Larson, A. C. (2015).

MRI-monitored intra-tumoral injection of iron-oxide labeled Clostridium novyi-NT anaerobes in pan-

creatic carcinoma mouse model. PLoS ONE, 9(12), e116204. https://doi.org/10.1371/jour-

nal.pone.0116204.